Antifungal drugs in pregnancy: a review

The use of any medication in pregnant women requires careful consideration of benefit to the mother versus risk posed to the fetus. Fungal infections are not uncommon in pregnant women; in fact, the incidence of certain infections such as Candida vaginitis is increased in this patient population. A variety of antimycotic agents are currently available to treat systemic or mucocutaneous fungal infections. Many of these agents are capable of penetrating the placental barrier and entering fetal cord blood, therefore adverse effects of these agents on the fetus are a valid concern. The use of topical azoles for the treatment of superficial fungal infections is safe and efficacious. However, there are some data suggesting a dose-related increase in the risk of teratogenicity associated with the use of systemic azoles. Amphotericin B remains the drug of choice for the treatment of systemic fungal infections in pregnancy. There are serious risks of fetal malformations associated with the use of griseofulvin, ketoconazole, voriconazole, flucytosine and potassium iodide. These drugs are contraindicated in pregnancy. There are insufficient data regarding the use of caspofungin in pregnancy. This article will review available data regarding the safety of antifungal drug use in pregnant women.

[1]  M. Klepser,et al.  In Vitro Activity of Micafungin (FK-463) against Candida spp.: Microdilution, Time-Kill, and Postantifungal-Effect Studies , 2002, Antimicrobial Agents and Chemotherapy.

[2]  D. Schmatz,et al.  The Antifungal Echinocandin Caspofungin Acetate Kills Growing Cells of Aspergillus fumigatus In Vitro , 2002, Antimicrobial Agents and Chemotherapy.

[3]  W. Levine,et al.  SEXUALLY TRANSMITTED DISEASES TREATMENT GUIDELINES 2002 , 2002, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[4]  D. Denning.  Echinocandins: a new class of antifungal. , 2002, The Journal of antimicrobial chemotherapy.

[5]  G. Koren,et al.  Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study. , 2000, American journal of obstetrics and gynecology.

[6]  J. Sobel.  Use of Antifungal Drugs in Pregnancy , 2000, Drug safety.

[7]  J. Sobel,et al.  Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  R. Schwartz,et al.  Discovery of Novel Antifungal (1,3)-β-d-Glucan Synthase Inhibitors , 2000, Antimicrobial Agents and Chemotherapy.

[9]  S. Jick.  Pregnancy Outcomes after Maternal Exposure to Fluconazole , 1999, Pharmacotherapy.

[10]  J. Cleary,et al.  Antifungal therapy during pregnancy. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  R. Gibbs,et al.  Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group. , 1998, American journal of obstetrics and gynecology.

[12]  P. Nyirjesy,et al.  Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. , 1998, American journal of obstetrics and gynecology.

[13]  R. Gibbs,et al.  Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group. , 1998, American journal of obstetrics and gynecology.

[14]  D. Bartley,et al.  Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient. , 1997, American journal of medical genetics.

[15]  P. Mastroiacovo,et al.  Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole. , 1996, American journal of obstetrics and gynecology.

[16]  J. Abraham,et al.  Fluconazole-induced congenital anomalies in three infants. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  A. Ranzini,et al.  Use of amphotericin B during pregnancy: case report and review. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  E. Shalev,et al.  Intraamniotic infection with Candida albicans successfully treated with transcervical amnioinfusion of amphotericin. , 1994, American journal of obstetrics and gynecology.

[19]  L. Gradoni,et al.  Mediterranean visceral leishmaniasis in pregnancy. , 1994, Scandinavian journal of infectious diseases.

[20]  P. Sohnle.  Candidiasis: Pathogenesis, diagnosis and treatment (2nd edn) , 1993 .

[21]  G. Tiboni.  Second branchial arch anomalies induced by fluconazole, a bis-triazole antifungal agent, in cultured mouse embryos. , 1993, Research communications in chemical pathology and pharmacology.

[22]  M. Glezerman,et al.  Asymptomatic amniotic fluid invasion with Candida albicans in preterm premature rupture of membranes: Implications for obstetric and neonatal management , 1993, Acta obstetricia et gynecologica Scandinavica.

[23]  A. R. Murthy,et al.  Congenital malformations in an infant born to a woman treated with fluconazole. , 1992, The Pediatric infectious disease journal.

[24]  L. Fernando,et al.  Transfusion-acquired hepatitis A outbreak from fresh frozen plasma in a neonatal intensive care unit. , 1992, The Pediatric infectious disease journal.

[25]  M. Niederman,et al.  Pneumonia complicating pregnancy. , 1992, Clinics in chest medicine.

[26]  P. Moerman,et al.  Intra-uterine Candida infection: a report of four infected fetusses from two mothers. , 1991, European journal of obstetrics, gynecology, and reproductive biology.

[27]  C. Pesquera,et al.  Successful treatment with ketoconazole of Cushing's syndrome in pregnancy. , 1990, Postgraduate medical journal.

[28]  A. P. Kiriushchenkov.  [Genital candidiasis]. , 1990, Fel'dsher i akusherka.

[29]  LisbethB. Knudsen.  NO ASSOCIATION BETWEEN GRISEOFULVIN AND CONJOINED TWINNING , 1987, The Lancet.

[30]  N. Sonino.  The use of ketoconazole as an inhibitor of steroid production. , 1987, The New England journal of medicine.

[31]  C. Baum,et al.  Pregnancy outcomes after first-trimester vaginitis drug therapy. , 1987, Obstetrics and gynecology.

[32]  FranzW. Rosa,et al.  GRISEOFULVIN TERATOLOGY, INCLUDING TWO THORACOPAGUS CONJOINED TWINS , 1987, The Lancet.

[33]  I. Cohen.  Absence of congenital infection and teratogenesis in three children born to mothers with blastomycosis and treated with amphotericin B during pregnancy. , 1987, The Pediatric infectious disease journal.

[34]  J. Sobel.  Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. , 1985, American journal of obstetrics and gynecology.

[35]  A. Chow,et al.  Pharmacokinetics and safety of antimicrobial agents during pregnancy. , 1985, Reviews of infectious diseases.

[36]  J. Mcgregor,et al.  Contraindication of ketoconazole in pregnancy. , 1984, American journal of obstetrics and gynecology.

[37]  A. Catanzaro,et al.  Pulmonary mycosis in pregnant women. , 1984, Chest.

[38]  H. Weintraub,et al.  Disposition of radioactivity following intravaginal administration of 3H-miconazole nitrate. , 1983, American journal of obstetrics and gynecology.

[39]  A. Espinel-Ingroff,et al.  Cryptococcal Meningitis in Pregnancy , 1983, Obstetrics and gynecology.

[40]  P. Mehta,et al.  Congenital Iodide Goiter and Hypothyroidism: A Review , 1983 .

[41]  W. Ritter,et al.  Pharmacokinetic fundamentals of vaginal treatment with clotrimazole. , 1985, Chemotherapy.

[42]  J. Voorhees,et al.  Sporotrichosis in pregnancy. , 1982, Cutis.

[43]  Ismail Ma,et al.  Disseminated blastomycosis in a pregnant woman: review of amphotericin B usage during pregnancy. , 1982, The American review of respiratory disease.

[44]  S. Lerner,et al.  Disseminated blastomycosis in a pregnant woman: review of amphotericin B usage during pregnancy. , 1982, The American review of respiratory disease.

[45]  Curole Dn.  Cryptococcal meningitis in pregnancy. , 1981 .

[46]  R. Nation.  Drug Kinetics in Childbirth , 1980, Clinical pharmacokinetics.

[47]  R. Punnonen,et al.  VAGINAL YEASTS IN PARTURIENTS AND INFESTATION OF THE NEWBORNS , 1980, Acta obstetricia et gynecologica Scandinavica.

[48]  R. Diasio,et al.  Evidence for Conversion of 5-Fluorocytosine to 5-Fluorouracil in Humans: Possible Factor in 5-Fluorocytosine Clinical Toxicity , 1978, Antimicrobial Agents and Chemotherapy.

[49]  K. Haram,et al.  Vulvovaginal Candidiasis in Pregnancy Treated with Clotrimazole , 1978, Acta obstetricia et gynecologica Scandinavica.

[50]  D. McNellis,et al.  Treatment of Vulvovaginal Candidiasis in Pregnancy: A Comparative Study , 1977, Obstetrics and gynecology.

[51]  F. Krauer,et al.  Drug Kinetics in Pregnancy , 1977, Clinical pharmacokinetics.

[52]  A. Gad,et al.  The frequency of Candida infections in pregnancy and their treatment with clotrimazole. , 1977, Current medical research and opinion.

[53]  B. Mirkin.  Perinatal Pharmacology: Placental Transfer, Fetal Localization, and Neonatal Disposition of Drugs , 1975, Anesthesiology.

[54]  Davis Je,et al.  Comparative evaluation of Monistat and Mycostatin in the treatment of vulvovaginal candidiasis. , 1974 .

[55]  J. Davis,et al.  Comparative Evaluation of Monistat and Mycostatin in the Treatment of Vulvovaginal Candidiasis , 1974, Obstetrics and gynecology.

[56]  Higton Bk.  A trial of clotrimazole and nystatin in vaginal candidiasis. , 1974 .

[57]  Goodwin Cs,et al.  A comparative trial of six day therapy with clotrimazole and nystatin in pregnant patients with vaginal candidiasis. , 1974 .

[58]  B. Higton.  A trial of clotrimazole and nystatin in vaginal candidiasis. , 1974, Postgraduate medical journal.

[59]  L. Milne,et al.  A comparative trial of six day therapy with clotrimazole and nystatin in pregnant patients with vaginal candidiasis. , 1974, Postgraduate medical journal.

[60]  J. Schönebeck,et al.  Candida albicans septicaemia during first half of pregnancy successfully treated with 5-fluorocytosine. , 1973, British medical journal.

[61]  K. Gull,et al.  Griseofulvin inhibits Fungal Mitosis , 1973, Nature.

[62]  J. Forfar,et al.  Epidemiology of drugs taken by pregnant women: Drugs that may affect the fetus adversely , 1973, Clinical pharmacology and therapeutics.

[63]  R. Hurley,et al.  CRITERIA FOR DIAGNOSIS OF CANDIDA VULVOVAGINITIS IN PREGNANT WOMEN , 1973, The Journal of obstetrics and gynaecology of the British Commonwealth.

[64]  C. Liu,et al.  Facial sporotrichosis during pregnancy. A therapeutic dilemma. , 1972, Archives of internal medicine.

[65]  J. Hutchison,et al.  Congenital goitre and hypothyroidism produced by maternal ingestion of iodides. , 1970, Lancet.

[66]  J. Wolff.  Iodide goiter and the pharmacologic effects of excess iodide. , 1969, The American journal of medicine.

[67]  W. Plauché.  Sporotrichosis in pregnancy. , 1968, American journal of obstetrics and gynecology.